HealthEquity Reports Second Quarter Ended July 31, 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Oppenheimer Remains Bullish on HealthEquity (HQY) Following Solid 2Q
September 6, 2017 9:44 AM EDTOppenheimer reiterated an Outperform rating and $61.00 price target on HealthEquity, Inc (NASDAQ: HQY) following the company's 2Q earnings report. Revenues of $56.9M beat estimates of $55.8M and adjusted EPS of $0.27 beat estimates of $0.18, mainly on tax benefits.
HQY raised its FY18... More
HealthEquity (HQY) Tops Q2 EPS by 12c, Sales Rise 29%; Raises Outlook
September 5, 2017 4:09 PM EDTHealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.27, $0.12 better than the analyst estimate of $0.15. Revenue for the quarter came in at $56.9 million versus the consensus estimate of $55.66 million.
Revenue of $56.9 million, an increase of 29% compared to Q2 FY17.Net income of $16.9 million, an increase of 106% compared to Q2 FY17.Net income per diluted share of $0.27 compared to $0.14 in Q2 FY17.Adjusted EBITDA of $23.9 million, an increase of 30% compared to Q2... More